Probiotics (Bacillus clausii) for Prevention of Late-onset Sepsis in Preterm Infants (<34 weeks): A Randomised Controlled Trial

Probiotics (Bacillus clausii) for Prevention of Late-onset Sepsis in Preterm Infants (<34 weeks): A Randomised Controlled Trial

Introduction: Late-onset Sepsis (LOS) causes significant morbidity and mortality in preterm infants. Probiotics have been suggested to improve the integrity of mucosal barrier by modifying the enteric microflora and suppress the overgrowth and translocation of pathogens in the gut, thus preventing l...

Full description

Bibliographic Details
Main Authors: P Namratha, Chinmayi R Joshi, Shailesh S Patil, Vijaykumar B Murteli
Format: Article
Language:English
Published: JCDR Research and Publications Pvt. Ltd. 2022-10-01
Series:Indian Journal of Neonatal Medicine and Research
Subjects:
enteral nutrition
gut microbiota
mucosal immunity
neonatal sepsis
Online Access:https://ijnmr.net/article_fulltext.aspx?issn=0973-709x&year=2022&month=October&volume=10&issue=4&page=PO01%20-%20PO05&id=2357

Internet

https://ijnmr.net/article_fulltext.aspx?issn=0973-709x&year=2022&month=October&volume=10&issue=4&page=PO01%20-%20PO05&id=2357

Similar Items